Previous Article | Next Article 
J Virol, March 1998, p. 2554-2559, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
In Vitro and In Vivo Oncogenic Potential of
Bovine Leukemia Virus G4 Protein
Pierre
Kerkhofs,1
Hubertine
Heremans,2
Arsène
Burny,3
Richard
Kettmann,3 and
Luc
Willems3,*
Department of Bovine Virology, Institut
National de Recherches Vétérinaires, B1120
Uccle,1
Rega Institute, University
of Leuven, B3000 Leuven,2 and
Department
of Molecular Biology, Faculté Universitaire des Sciences
Agronomiques, B5030 Gembloux,3 Belgium
Received 7 July 1997/Accepted 8 December 1997
In addition to the genes involved in the structure of the viral
particle, the bovine leukemia virus (BLV) genome contains a region
called X which contains at least four genes. Among them, the
tax and rex genes, respectively, are involved
in transcriptional and posttranscriptional regulation of viral
transcription. Two other genes, R3 and G4, were identified after
cloning of the corresponding mRNAs from BLV-infected lymphocytes.
Although the function of the two latter genes is still unknown, they
appear to have important roles, since deletion of them restricts viral
propagation in vivo. In order to assess the oncogenic potential of the
R3 and G4 proteins, we first analyzed their ability to immortalize
and/or transform primary rat embryo fibroblasts (Refs). In this assay,
the G4 but not the R3 protein cooperated with the Ha-ras
oncogene to induce tumors in nude mice. It thus appears that G4
exhibited oncogenic potential in vitro. To extend these observations in
vivo, the pathology induced by recombinant viruses with mutations in G4 and in R3 and G4 was next evaluated with the sheep animal model. Viral
propagation, as measured by semiquantitative PCR, appeared to be
reduced when the R3 and G4 genes were deleted. These observations confirm and extend our previous data underlining the biological function of these genes. In addition, we present the results of a
clinical survey that involves 39 sheep infected with six different BLV
recombinants. Over a period of 40 months, 83% of the sheep infected
with a wild-type virus developed leukemias and/or lymphosarcomas. In
contrast, none out of 13 sheep infected with viruses with mutations in
G4 or in R3 and G4 developed disease. We conclude that in addition to
its oncogenic potential in vitro, G4 is required for pathogenesis in
vivo. These observations should help us gain insight into the process
of leukemogenesis induced by the related human T-cell leukemia virus
type 1.
*
Corresponding author. Mailing address: Department of
Molecular Biology, Faculté Universitaire des Sciences
Agronomiques, B5030 Gembloux, Belgium. Phone: 32-81-622157. Fax:
32-81-613888. E-mail: willems.l{at}fsagx.ac.be.
This article has been cited by other articles:
-
Jung, K.-J., Dasgupta, A., Huang, K., Jeong, S.-J., Pise-Masison, C., Gurova, K. V., Brady, J. N.
(2008). Small-Molecule Inhibitor Which Reactivates p53 in Human T-Cell Leukemia Virus Type 1-Transformed Cells. J. Virol.
82: 8537-8547
[Abstract]
[Full Text]
-
Florins, A., Gillet, N., Boxus, M., Kerkhofs, P., Kettmann, R., Willems, L.
(2007). Even Attenuated Bovine Leukemia Virus Proviruses Can Be Pathogenic in Sheep. J. Virol.
81: 10195-10200
[Abstract]
[Full Text]
-
Florins, A., Gillet, N., Asquith, B., Debacq, C., Jean, G., Schwartz-Cornil, I., Bonneau, M., Burny, A., Reichert, M., Kettmann, R., Willems, L.
(2006). Spleen-Dependent Turnover of CD11b Peripheral Blood B Lymphocytes in Bovine Leukemia Virus-Infected Sheep. J. Virol.
80: 11998-12008
[Abstract]
[Full Text]
-
Hiraragi, H., Kim, S.-J., Phipps, A. J., Silic-Benussi, M., Ciminale, V., Ratner, L., Green, P. L., Lairmore, M. D.
(2006). Human T-Lymphotropic Virus Type 1 Mitochondrion-Localizing Protein p13II Is Required for Viral Infectivity In Vivo.. J. Virol.
80: 3469-3476
[Abstract]
[Full Text]
-
Hiraragi, H., Michael, B., Nair, A., Silic-Benussi, M., Ciminale, V., Lairmore, M.
(2005). Human T-Lymphotropic Virus Type 1 Mitochondrion-Localizing Protein p13II Sensitizes Jurkat T Cells to Ras-Mediated Apoptosis. J. Virol.
79: 9449-9457
[Abstract]
[Full Text]
-
Silic-Benussi, M., Cavallari, I., Zorzan, T., Rossi, E., Hiraragi, H., Rosato, A., Horie, K., Saggioro, D., Lairmore, M. D., Willems, L., Chieco-Bianchi, L., D'Agostino, D. M., Ciminale, V.
(2004). Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc. Natl. Acad. Sci. USA
101: 6629-6634
[Abstract]
[Full Text]
-
Motton, D. D., Buehring, G. C.
(2003). Bovine Leukemia Virus Alters Growth Properties and Casein Synthesis in Mammary Epithelial Cells. J DAIRY SCI
86: 2826-2838
[Abstract]
[Full Text]
-
D'Agostino, D. M., Ranzato, L., Arrigoni, G., Cavallari, I., Belleudi, F., Torrisi, M. R., Silic-Benussi, M., Ferro, T., Petronilli, V., Marin, O., Chieco-Bianchi, L., Bernardi, P., Ciminale, V.
(2002). Mitochondrial Alterations Induced by the p13II Protein of Human T-cell Leukemia Virus Type 1. CRITICAL ROLE OF ARGININE RESIDUES. J. Biol. Chem.
277: 34424-34433
[Abstract]
[Full Text]
-
Albrecht, B., Lairmore, M. D.
(2002). Critical Role of Human T-Lymphotropic Virus Type 1 Accessory Proteins in Viral Replication and Pathogenesis. Microbiol. Mol. Biol. Rev.
66: 396-406
[Abstract]
[Full Text]
-
Lefebvre, L., Ciminale, V., Vanderplasschen, A., D'Agostino, D., Burny, A., Willems, L., Kettmann, R.
(2002). Subcellular Localization of the Bovine Leukemia Virus R3 and G4 Accessory Proteins. J. Virol.
76: 7843-7854
[Abstract]
[Full Text]
-
Lefebvre, L., Vanderplasschen, A., Ciminale, V., Heremans, H., Dangoisse, O., Jauniaux, J.-C., Toussaint, J.-F., Zelnik, V., Burny, A., Kettmann, R., Willems, L.
(2002). Oncoviral Bovine Leukemia Virus G4 and Human T-Cell Leukemia Virus Type 1 p13II Accessory Proteins Interact with Farnesyl Pyrophosphate Synthetase. J. Virol.
76: 1400-1414
[Abstract]
[Full Text]
-
Van den Broeke, A., Cleuter, Y., Beskorwayne, T., Kerkhofs, P., Szynal, M., Bagnis, C., Burny, A., Griebel, P.
(2001). CD154 Costimulated Ovine Primary B Cells, a Cell Culture System That Supports Productive Infection by Bovine Leukemia Virus. J. Virol.
75: 1095-1103
[Abstract]
[Full Text]
-
Kerkhofs, P., Gatot, J.-S., Knapen, K., Mammerickx, M., Burny, A., Portetelle, D., Willems, L., Kettmann, R.
(2000). Long-term protection against bovine leukaemia virus replication in cattle and sheep. J. Gen. Virol.
81: 957-963
[Abstract]
[Full Text]
-
Reichert, M., Cantor, G. H., Willems, L., Kettmann, R.
(2000). Protective effects of a live attenuated bovine leukaemia virus vaccine with deletion in the R3 and G4 genes. J. Gen. Virol.
81: 965-969
[Abstract]
[Full Text]
-
Kucerova, L., Altanerova, V., Altaner, C., Boris-Lawrie, K.
(1999). Bovine Leukemia Virus Structural Gene Vectors Are Immunogenic and Lack Pathogenicity in a Rabbit Model. J. Virol.
73: 8160-8166
[Abstract]
[Full Text]
-
Rovnak, J., Casey, J. W.
(1999). Assessment of Bovine Leukemia Virus Transcripts In Vivo. J. Virol.
73: 8890-8897
[Abstract]
[Full Text]
-
Van Den Broeke, A., Bagnis, C., Ciesiolka, M., Cleuter, Y., Gelderblom, H., Kerkhofs, P., Griebel, P., Mannoni, P., Burny, A.
(1999). In Vivo Rescue of a Silent tax-Deficient Bovine Leukemia Virus from a Tumor-Derived Ovine B-Cell Line by Recombination with a Retrovirally Transduced Wild-Type tax Gene. J. Virol.
73: 1054-1065
[Abstract]
[Full Text]
-
Tajima, S., Ikawa, Y., Aida, Y.
(1998). Complete Bovine Leukemia Virus (BLV) Provirus Is Conserved in BLV-Infected Cattle throughout the Course of B-Cell Lymphosarcoma Development. J. Virol.
72: 7569-7576
[Abstract]
[Full Text]